PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 163 filers reported holding PDL BIOPHARMA INC in Q2 2018. The put-call ratio across all filers is 1.66 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $1,000 | -97.6% | 460 | -97.2% | 0.00% | -100.0% |
| Q3 2018 | $42,000 | +5.0% | 16,224 | -4.1% | 0.00% | -50.0% |
| Q2 2018 | $40,000 | -18.4% | 16,924 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $49,000 | +8.9% | 16,924 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $45,000 | -27.4% | 16,924 | -7.3% | 0.00% | -33.3% |
| Q3 2017 | $62,000 | +37.8% | 18,260 | 0.0% | 0.00% | +50.0% |
| Q2 2017 | $45,000 | +2.3% | 18,260 | -2.2% | 0.00% | 0.0% |
| Q1 2017 | $44,000 | -13.7% | 18,680 | -24.1% | 0.00% | -33.3% |
| Q4 2016 | $51,000 | -61.7% | 24,600 | -37.8% | 0.00% | -40.0% |
| Q3 2016 | $133,000 | +66.2% | 39,560 | +54.8% | 0.01% | 0.0% |
| Q2 2016 | $80,000 | -12.1% | 25,560 | -6.4% | 0.01% | -16.7% |
| Q1 2016 | $91,000 | +18.2% | 27,308 | +25.5% | 0.01% | +20.0% |
| Q4 2015 | $77,000 | -18.1% | 21,757 | +20.0% | 0.01% | -16.7% |
| Q3 2015 | $94,000 | -27.1% | 18,129 | +9.0% | 0.01% | -33.3% |
| Q4 2014 | $129,000 | +6.6% | 16,629 | +3.1% | 0.01% | +12.5% |
| Q3 2014 | $121,000 | -22.4% | 16,129 | 0.0% | 0.01% | -20.0% |
| Q2 2014 | $156,000 | +20.9% | 16,129 | +4.1% | 0.01% | +11.1% |
| Q1 2014 | $129,000 | -15.7% | 15,500 | -15.3% | 0.01% | -25.0% |
| Q4 2013 | $153,000 | +2.0% | 18,290 | -3.2% | 0.01% | -7.7% |
| Q3 2013 | $150,000 | +4.9% | 18,890 | +2.7% | 0.01% | -7.1% |
| Q2 2013 | $143,000 | – | 18,390 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |